OHSU News

Greetings. Here are your latest headlines from OHSU News. You can find up-to-date information on OHSU's response to the COVID-19 pandemic here.

Tracking virus variants across Oregon, Southwest Washington

Tracking virus variants across Oregon, Southwest Washington

New federal and state awards will expand OHSU’s research and clinical capacity for genome sequencing.
OHSU research is latest to characterize potential end of COVID-19 pandemic

OHSU research is latest to characterize potential end of COVID-19 pandemic

Lab results suggest durable immunity against variants.
Myocarditis and COVID-19 vaccine: Patient case studies demonstrate easily treated symptoms

Myocarditis and COVID-19 vaccine: Patient case studies demonstrate easily treated symptoms

Review of seven cases of heart muscle inflammation following mRNA vaccine suggests, based on current data, COVID-19 vaccine benefits overwhelmingly outweigh the low risk of developing myocarditis.
New gene therapy uses Tylenol to combat genetic diseases

New gene therapy uses Tylenol to combat genetic diseases

Novel approach corrects disease-causing mutations by making treated livers cells immune to acetaminophen.
Monoclonal antibody prevents HIV infection in monkeys, study finds

Monoclonal antibody prevents HIV infection in monkeys, study finds

Leronlimab to be studied as potential HIV PrEP drug in an early human clinical trial.